Modulating anti-GD2 immunotherapy via dual DFMO and TGF-β inhibition in neuroblastoma

被引：0
|
作者：
Gandhi, Om H.
Turn, Christina S.
Liu, Kangning
Vu, Annette T.
Bassiri, Hamid
Hogarty, Michael D.
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-5122
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5122
引用
收藏
页数：2
相关论文
共 50 条
  • [21] In Vivo Validation of Trogocytosis in Neuroblastoma: A Potential Novel Mechanism of Resistance to Anti-GD2 Immunotherapy
    Zamora, Abigail K.
    Zobel, Michael John
    Sheard, Michael Allen
    Seeger, Robert Charles
    Kim, Eugene Sung-Kyun
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2020, 231 (04) : S203 - S203
  • [22] Anti-GD2 induced allodynia in rats can be reduced by pretreatment with DFMO
    Diccianni, Mitchell B.
    Kempinska, Katarzyna
    Gangoti, Jon A.
    Yu, Alice L.
    Sorkin, Linda S.
    PLOS ONE, 2020, 15 (07): : e0236115
  • [23] Dual-labeled anti-GD2 targeted probe for intraoperative molecular imaging of neuroblastoma
    Rosenblum, Lauren Taylor
    Sever, ReidAnn E.
    Gilbert, Ryan
    Guerrero, David
    Vincze, Sarah R.
    Menendez, Dominic M.
    Birikorang, Peggy A.
    Rodgers, Mikayla R.
    Jaswal, Ambika Parmar
    Vanover, Alexander C.
    Latoche, Joseph D.
    Cortez, Angel G.
    Day, Kathryn E.
    Foley, Lesley M.
    Sneiderman, Chaim T.
    Raphael, Itay
    Hitchens, T. Kevin
    Nedrow, Jessie R.
    Kohanbash, Gary
    Edwards, W. Barry
    Malek, Marcus M.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [24] Anti-GD2 mAb and Vorinostat synergize in the treatment of neuroblastoma
    Kroesen, Michiel
    Bull, Christian
    Gielen, Paul R.
    Brok, Ingrid C.
    Armandari, Inna
    Wassink, Melissa
    Looman, Maaike W. G.
    Boon, Louis
    den Brok, Martijn H.
    Hoogerbrugge, Peter M.
    Adema, Gosse J.
    ONCOIMMUNOLOGY, 2016, 5 (06):
  • [25] PHOTOIMMUNOTHERAPY USING ANTI-GD2 ANTIBODY FOR NEUROBLASTOMA AND OSTEOSARCOMA
    Zhao, Jimei
    Ueki, Masahiro
    Nakajima, Kohei
    Terashita, Yukayo
    Hirabayashi, Shinsuke
    Cho, Yuko
    Ogawa, Mikako
    Manabe, Atsushi
    PEDIATRIC BLOOD & CANCER, 2024, 71 : S5 - S5
  • [26] ANTI-GD2 IMMUNOTHERAPY WITH G-CSF AND INTERLEUKIN-2 FOR HIGH-RISK NEUROBLASTOMA
    Honda, Mamoru
    Arakawa, Yuki
    Kaneko, Ryota
    Kubota, Hirohito
    Mitani, Yuichi
    Mori, Makiko
    Fukuoka, Kohei
    Oshima, Koichi
    Isshiki, Kyohei
    Koh, Katsuyoshi
    PEDIATRIC BLOOD & CANCER, 2022, 69
  • [27] MYCN-amplified stage 2/3 neuroblastoma: excellent survival in the era of anti-GD2 immunotherapy
    Kushner, Brian H.
    LaQuaglia, Michael P.
    Modak, Shakeel
    Wolden, Suzanne L.
    Basu, Ellen M.
    Roberts, Stephen S.
    Kramer, Kim
    Yataghene, Karima
    Cheung, Irene Y.
    Cheung, Nai-Kong V.
    ONCOTARGET, 2017, 8 (56) : 95293 - 95302
  • [28] Engineering anti-GD2 monoclonal antibodies for cancer immunotherapy
    Ahmed, Mahiuddin
    Cheung, Nai-Kong V.
    FEBS LETTERS, 2014, 588 (02): : 288 - 297
  • [29] Multidisciplinary Clinical Care in the Management of Patients Receiving Anti-GD2 Immunotherapy for High-Risk Neuroblastoma
    Cabral, Jennifer
    Fernandez, Erica, I
    Toy, Bonnie
    Secola, Rita
    PEDIATRIC DRUGS, 2023, 25 (01) : 13 - 25
  • [30] Multidisciplinary Clinical Care in the Management of Patients Receiving Anti-GD2 Immunotherapy for High-Risk Neuroblastoma
    Jennifer Cabral
    Erica I. Fernandez
    Bonnie Toy
    Rita Secola
    Pediatric Drugs, 2023, 25 : 13 - 25
12345